Cancer testing company to pay $900K to settle Stark Law violation allegations

Palo Alto, Calif.-based oncology company Guardant Health will pay $913,933 to settle allegations it violated Stark Law. 

Advertisement

The Justice Department alleged that Guardant submitted claims and received payments from Medicare for laboratory services that had been referred in violation of Stark Law. Guardant also allegedly knowingly submitted or caused the submission of false claims for payments. 

In April 2021, a physician in Austin, Texas, contacted Guardant’s human resources department to recommend a family friend for an account manager position, according to a July 18 news release from the Justice Department. The family friend was hired. 

In October 2021, the physician sought a position for his stepdaughter, who was considered, but rejected, for a position in the company’s screening division. 

In February 2022, two Guardant employees arranged for the family friend to be promoted, opening a role in the oncology division for the stepdaughter. The two employees knew about the relationship and knew the stepdaughter was not qualified for the role. 

According to the report, the “physician then ordered significantly more Guardant tests per quarter after both hirings.”

Guardant, who voluntarily disclosed the conduct to the HHS, will also pay $31,082 in an administrative settlement with the Defense Health Agency.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in ASC Coding, Billing & Collections

Advertisement

Comments are closed.